Satsuma Pharmaceuticals Inc (STSA) stock has fallen -70.71% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives STSA stock a score of 19 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. STSA's rank also includes a short-term technical score of 22. The fundamental score for STSA is 31. In addition to the average rating from Wall Street analysts, STSA stock has a mean target price of 5. This means analysts expect the stock to lose 10.07% over the next 12 months.
What's Happening with STSA Stock Today
Satsuma Pharmaceuticals Inc (STSA) stock is higher by 10.56% while the S&P 500 has fallen -0.46% as of 3:01 PM on Friday, Jan 15. STSA is up $0.53 from the previous closing price of $5.03 on volume of 339,966 shares. Over the past year the S&P 500 has gained 13.90% while STSA has fallen -70.71%. STSA lost -$2.64 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Satsuma Pharmaceuticals Inc (STSA) Stock.